Cargando…

Risk Factors and Management for Epistaxis in a Hospitalized Adult Sample

INTRODUCTION: Epistaxis is a common otolaryngologic problem that affects most of the general population. Common risk factors for epistaxis include nasal irritants, nasal/facial oxygen use, certain systemic conditions (e.g., hypertension and coagulopathies) and medication use (e.g., anticoagulants an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Andrew, Engebretsen, Steven, Mahoney, Rebecca, Bathula, Samba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MSU College of Osteopathic Medicine Statewide Campus System 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448657/
https://www.ncbi.nlm.nih.gov/pubmed/36128022
http://dx.doi.org/10.51894/001c.37760
_version_ 1784784113355456512
author Ross, Andrew
Engebretsen, Steven
Mahoney, Rebecca
Bathula, Samba
author_facet Ross, Andrew
Engebretsen, Steven
Mahoney, Rebecca
Bathula, Samba
author_sort Ross, Andrew
collection PubMed
description INTRODUCTION: Epistaxis is a common otolaryngologic problem that affects most of the general population. Common risk factors for epistaxis include nasal irritants, nasal/facial oxygen use, certain systemic conditions (e.g., hypertension and coagulopathies) and medication use (e.g., anticoagulants and intranasal medications). This study examined risk factors for and management of epistaxis in patients admitted for other medical conditions who developed an episode of epistaxis during their hospital admission. METHODS: Patients were included in the study if they were older than 18, admitted for medical illnesses other than epistaxis and developed an episode of epistaxis during their admission during calendar year 2020 at the authors’ institution’s hospitals. Electronic health record data regarding sociodemographic characteristics, common risk factors (e.g. oxygen use, anticoagulant use, history of hypertension) and treatment for epistaxis (e.g. holding anticoagulation therapy, administration of oxymetazoline, nasal cautery, nasal packing) were extracted from each chart. Patients were split into otolaryngologic treatment versus no treatment groups and risk factors were compared between sample subgroups. RESULTS: A total of 143 sample patients were included, with most common reason for admission being cardiovascular related, 48 (33.6%). Most patients, 104 (72.7%), did not have a previous diagnosis of epistaxis, were positive for anticoagulant use, 106 (74.1%) and were positive for hypertension, 95 (66.4%). Oxygen use showed a significantly decreased risk for intervention (OR 0.45, 95% CI: 0.23-0.894; p = 0.028). Most patients required changes in medical management (e.g., holding anticoagulation or starting nasal saline sprays/emollients). CONCLUSION: These results demonstrate the common risk factors for epistaxis in patients admitted for other clinical diseases. Identifying at-risk patients for epistaxis at hospital admission can help to initiate measures to prevent epistaxis episodes. Future studies are needed to study epistaxis risk factors and identify effective preventative measures for epistaxis among hospital populations.
format Online
Article
Text
id pubmed-9448657
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MSU College of Osteopathic Medicine Statewide Campus System
record_format MEDLINE/PubMed
spelling pubmed-94486572022-09-19 Risk Factors and Management for Epistaxis in a Hospitalized Adult Sample Ross, Andrew Engebretsen, Steven Mahoney, Rebecca Bathula, Samba Spartan Med Res J Original Contribution INTRODUCTION: Epistaxis is a common otolaryngologic problem that affects most of the general population. Common risk factors for epistaxis include nasal irritants, nasal/facial oxygen use, certain systemic conditions (e.g., hypertension and coagulopathies) and medication use (e.g., anticoagulants and intranasal medications). This study examined risk factors for and management of epistaxis in patients admitted for other medical conditions who developed an episode of epistaxis during their hospital admission. METHODS: Patients were included in the study if they were older than 18, admitted for medical illnesses other than epistaxis and developed an episode of epistaxis during their admission during calendar year 2020 at the authors’ institution’s hospitals. Electronic health record data regarding sociodemographic characteristics, common risk factors (e.g. oxygen use, anticoagulant use, history of hypertension) and treatment for epistaxis (e.g. holding anticoagulation therapy, administration of oxymetazoline, nasal cautery, nasal packing) were extracted from each chart. Patients were split into otolaryngologic treatment versus no treatment groups and risk factors were compared between sample subgroups. RESULTS: A total of 143 sample patients were included, with most common reason for admission being cardiovascular related, 48 (33.6%). Most patients, 104 (72.7%), did not have a previous diagnosis of epistaxis, were positive for anticoagulant use, 106 (74.1%) and were positive for hypertension, 95 (66.4%). Oxygen use showed a significantly decreased risk for intervention (OR 0.45, 95% CI: 0.23-0.894; p = 0.028). Most patients required changes in medical management (e.g., holding anticoagulation or starting nasal saline sprays/emollients). CONCLUSION: These results demonstrate the common risk factors for epistaxis in patients admitted for other clinical diseases. Identifying at-risk patients for epistaxis at hospital admission can help to initiate measures to prevent epistaxis episodes. Future studies are needed to study epistaxis risk factors and identify effective preventative measures for epistaxis among hospital populations. MSU College of Osteopathic Medicine Statewide Campus System 2022-09-06 /pmc/articles/PMC9448657/ /pubmed/36128022 http://dx.doi.org/10.51894/001c.37760 Text en https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (4.0) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Contribution
Ross, Andrew
Engebretsen, Steven
Mahoney, Rebecca
Bathula, Samba
Risk Factors and Management for Epistaxis in a Hospitalized Adult Sample
title Risk Factors and Management for Epistaxis in a Hospitalized Adult Sample
title_full Risk Factors and Management for Epistaxis in a Hospitalized Adult Sample
title_fullStr Risk Factors and Management for Epistaxis in a Hospitalized Adult Sample
title_full_unstemmed Risk Factors and Management for Epistaxis in a Hospitalized Adult Sample
title_short Risk Factors and Management for Epistaxis in a Hospitalized Adult Sample
title_sort risk factors and management for epistaxis in a hospitalized adult sample
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448657/
https://www.ncbi.nlm.nih.gov/pubmed/36128022
http://dx.doi.org/10.51894/001c.37760
work_keys_str_mv AT rossandrew riskfactorsandmanagementforepistaxisinahospitalizedadultsample
AT engebretsensteven riskfactorsandmanagementforepistaxisinahospitalizedadultsample
AT mahoneyrebecca riskfactorsandmanagementforepistaxisinahospitalizedadultsample
AT bathulasamba riskfactorsandmanagementforepistaxisinahospitalizedadultsample